Search

Your search keyword '"Schröder, Carolina P."' showing total 31 results
Start Over Author "Schröder, Carolina P." Publisher american association for cancer research (aacr)
31 results on '"Schröder, Carolina P."'

1. Figure S6 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

2. Figure S1 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

3. Figure S5 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

4. Supplementary Data 1 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

5. Supplementary Data 1 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

6. Figure S3 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

7. Figure S7 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

8. Figure S5 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

9. Figure S3 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

10. Figure S2 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

11. Figure S6 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

12. Figure S2 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

13. Data from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

14. Figure S4 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

15. Figure S7 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

16. Figure S1 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

17. Figure S4 from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

18. Data from Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, primary, Cuypere, Eveline, primary, Dalenc, Florence, primary, Dirix, Luc, primary, Chan, Steve, primary, Marme, Frederik, primary, Schröder, Carolina P., primary, Huober, Jens, primary, Duhoux, Francois P., primary, Vuylsteke, Peter, primary, Jager, Agnes, primary, Brain, Etienne, primary, Kuemmel, Sherko, primary, Pápai, Zsuzsanna, primary, Menke-van der Houven van Oordt, Catharina Willemien, primary, Perjesi, Luca, primary, Mueller, Christian, primary, Brignone, Chrystelle, primary, and Triebel, Frederic, primary

Published
2024
Full Text
View/download PDF

19. Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial

Author

Wildiers, Hans, primary, Armstrong, Anne, additional, Cuypere, Eveline, additional, Dalenc, Florence, additional, Dirix, Luc, additional, Chan, Steve, additional, Marme, Frederik, additional, Schröder, Carolina P., additional, Huober, Jens, additional, Duhoux, Francois P., additional, Vuylsteke, Peter, additional, Jager, Agnes, additional, Brain, Etienne, additional, Kuemmel, Sherko, additional, Pápai, Zsuzsanna, additional, Menke-van der Houven van Oordt, Catharina Willemien, additional, Perjesi, Luca, additional, Mueller, Christian, additional, Brignone, Chrystelle, additional, and Triebel, Frederic, additional

Published
2023
Full Text
View/download PDF

20. Supplementary Figure Legend from Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake

Author

Arjaans, Marlous, primary, Oude Munnink, Thijs H., primary, Oosting, Sjoukje F., primary, Terwisscha van Scheltinga, Anton G.T., primary, Gietema, Jourik A., primary, Garbacik, Erik T., primary, Timmer-Bosscha, Hetty, primary, Lub-de Hooge, Marjolijn N., primary, Schröder, Carolina P., primary, and de Vries, Elisabeth G.E., primary

Published
2023
Full Text
View/download PDF

21. Supplementary Figure 1 from Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake

Author

Arjaans, Marlous, primary, Oude Munnink, Thijs H., primary, Oosting, Sjoukje F., primary, Terwisscha van Scheltinga, Anton G.T., primary, Gietema, Jourik A., primary, Garbacik, Erik T., primary, Timmer-Bosscha, Hetty, primary, Lub-de Hooge, Marjolijn N., primary, Schröder, Carolina P., primary, and de Vries, Elisabeth G.E., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figure 1 from Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake

Author

Arjaans, Marlous, primary, Oude Munnink, Thijs H., primary, Oosting, Sjoukje F., primary, Terwisscha van Scheltinga, Anton G.T., primary, Gietema, Jourik A., primary, Garbacik, Erik T., primary, Timmer-Bosscha, Hetty, primary, Lub-de Hooge, Marjolijn N., primary, Schröder, Carolina P., primary, and de Vries, Elisabeth G.E., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Figure Legend from Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake

Author

Arjaans, Marlous, primary, Oude Munnink, Thijs H., primary, Oosting, Sjoukje F., primary, Terwisscha van Scheltinga, Anton G.T., primary, Gietema, Jourik A., primary, Garbacik, Erik T., primary, Timmer-Bosscha, Hetty, primary, Lub-de Hooge, Marjolijn N., primary, Schröder, Carolina P., primary, and de Vries, Elisabeth G.E., primary

Published
2023
Full Text
View/download PDF

25. Abstract LB037: 89ZED88082A PET imaging to visualize CD8+ T cells in patients with cancer treated with immune checkpoint inhibitor

Author

de Ruijter, Laura Kist, primary, van de Donk, Pim P., additional, Hooiveld-Noeken, Jahlisa S., additional, Giesen, Danique, additional, Ungewickell, Alexander, additional, Fine, Bernard M., additional, Williams, Simon P., additional, Bohorquez, Sandra M. Sanabria, additional, Yadav, Mahesh, additional, Koeppen, Hartmut, additional, Jing, Jing, additional, Guelman, Sebastian, additional, Lin, Mark T., additional, Mamounas, Michael J., additional, Eastham, Jeffrey, additional, Kimes, Patrick K., additional, Glaudemans, Andor W., additional, Brouwers, Adrienne H., additional, Lub-de Hooge, Marjolijn N., additional, Gietema, Jourik A., additional, Schröder, Carolina P., additional, Timens, Wim, additional, Jalving, Mathilde, additional, Elias, Sjoerd, additional, Oosting, Sjoukje F., additional, de Groot, Derk J., additional, and de Vries, Elisabeth G., additional

Published
2021
Full Text
View/download PDF

30. Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake

Author

Arjaans, Marlous, primary, Oude Munnink, Thijs H., additional, Oosting, Sjoukje F., additional, Terwisscha van Scheltinga, Anton G.T., additional, Gietema, Jourik A., additional, Garbacik, Erik T., additional, Timmer-Bosscha, Hetty, additional, Lub-de Hooge, Marjolijn N., additional, Schröder, Carolina P., additional, and de Vries, Elisabeth G.E., additional

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results